Allogene Therapeutics, Inc. (Nasdaq: ALLO), a clinical-stage biotechnology company pioneering the development of allogeneic CAR T (AlloCAR T™) therapies for cancer, and Notch Therapeutics Inc., an immune cell therapy company creating universally compatible, allogeneic T cell therapies for the treatment of diseases of high unmet need, today announced an exclusive worldwide collaboration and license agreement to research and develop induced…
Read More

CBR Member Feature: Maria-Elizabeth Baeva, BSc

People who change your opinions about life come in all forms. For me, these forms usually entail lab coats and nitrile gloves. One of these PPE-endowed people is a Master of Science candidate in the laboratory of Dr. Wilfred Jeffries named Maria-Elizabeth Baeva. Before I met Maria, I was convinced that all successful graduate students devoted the majority of their…
Read More
Although breast cancer treatment has made great strides, around 5,000 Canadian women are still expected to succumb to the disease in 2019 alone. And it’s not the breast tumour that will kill them; it’s the spread of the cancer cells to other sites—a process called metastasis. Karla Williams, a professor in the faculty of pharmaceutical sciences at UBC and the…
Read More

Vienna Lam, Lab Manager at SFU, Featured on Best of the WWEST Podcast

In this episode, we hear from Vienna Lam, the Lab Manager at the SFU Centre for Forensic Research and School of Criminology. She tells host Danniele about her love for learning, which took her from a bachelor degree to a second bachelor degree to a master’s degree. You’ll hear about her passion for the whole research cycle as well as…
Read More
The University of British Columbia will host the first Canadian concert bringing leading musical talents of Vienna together with dramatic narratives from science and medicine. “Sounds and Science: Vienna Vancouver” is part of the President’s Concert Series, to be held Nov. 30, 2019 on UBC campus. The event is modeled on a successful concert series launched in Austria in 2014, in cooperation with…
Read More
An analysis of more than 9,000 brain scans shows that abnormalities in brain function in mood and anxiety disorders are localized to the same areas of the brain, offering promise for future prevention and treatment. The research, published today in the journal JAMA Psychiatry, identified brain regions showing either abnormally increased (hyper-activation) or abnormally decreased (hypo-activation) activation in people with mood and…
Read More
Cells and tissues are decorated by sugars that enable many physiological and pathophysiological processes. The ability to analyze, characterize, and manipulate these sugar structures is vital in basic and applied research, as well as in medicine. Using a metagenomic screening approach, researchers from the laboratory of Prof. Steve Withers, in collaboration with the laboratory of Prof. Steven Hallam, identified new enzymes (N-acetylgalactosaminidases)…
Read More
Pascal Biosciences Inc. (TSX.V:PAS) (“Pascal”) and Y-Biologics (together the “Companies”) today announced a research collaboration agreement for the discovery and development of novel bispecific antibodies for the treatment of leukemia. Under the terms of the agreement, Y-Biologics will contribute its novel bispecific antibody platform technology, ALiCE, and Pascal will utilize its proprietary antibodies. The Companies will share responsibility for the discovery and validation…
Read More
Cannabis flowers with the most mushroom-shaped hairs pack the biggest cannabinoid and fragrance punch, according to new research from the University of British Columbia. While the cannabis leaf is iconic, it’s the chemicals produced by the tiny, frostlike hairs on cannabis flowers that give the plant its psychoactive and medicinal properties and distinctive smell. In a study published in The Plant…
Read More